CH533095A - Verfahren zur Herstellung von Androstan-Verbindungen - Google Patents
Verfahren zur Herstellung von Androstan-VerbindungenInfo
- Publication number
- CH533095A CH533095A CH955170A CH955170A CH533095A CH 533095 A CH533095 A CH 533095A CH 955170 A CH955170 A CH 955170A CH 955170 A CH955170 A CH 955170A CH 533095 A CH533095 A CH 533095A
- Authority
- CH
- Switzerland
- Prior art keywords
- production
- androstane compounds
- androstane
- compounds
- Prior art date
Links
- 150000001441 androstanes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84587769A | 1969-07-29 | 1969-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH533095A true CH533095A (de) | 1973-01-31 |
Family
ID=25296306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH955170A CH533095A (de) | 1969-07-29 | 1970-06-24 | Verfahren zur Herstellung von Androstan-Verbindungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3580937A (de) |
| BE (1) | BE754111A (de) |
| CH (1) | CH533095A (de) |
| DE (1) | DE2035738A1 (de) |
| FR (1) | FR2059572B1 (de) |
| GB (1) | GB1279186A (de) |
| IL (1) | IL34974A (de) |
| NL (1) | NL7009586A (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5804576A (en) * | 1983-08-02 | 1998-09-08 | Research Corporation Technologies, Inc. | Derivatives of 5-androsten-17-ones and 5-androstan-17-ones |
| AU582122B2 (en) * | 1983-08-02 | 1989-03-16 | Research Corporation | Steroids useful as anti-cancer,anti-obesity, anti-hyperglycemic,anti-autoimmune and anti-hyperchlesterolemic agents |
| US5656621A (en) * | 1983-08-02 | 1997-08-12 | Research Corporation Tech., Inc. | Steroids useful as anti-cancer and anti-obesity agents |
| US5714481A (en) * | 1983-08-02 | 1998-02-03 | Research Corporation Technologies, Inc. | Derivatives of 5-androsten-17 ones and 5-androstan-17-ones |
| US5001119A (en) * | 1987-11-25 | 1991-03-19 | Schwartz Arthur G | 16-substituted androstanes and 16-substituted androstenes |
| US5028631A (en) * | 1987-11-25 | 1991-07-02 | Schwartz Arthur G | Homoandrostan-17-one and homoandrosten-17-ones |
| US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
| US4898694A (en) * | 1987-11-25 | 1990-02-06 | Schwartz Arthur G | 17-Hydroxy-steroids |
| DK1955700T3 (da) | 1999-09-30 | 2011-05-23 | Harbor Biosciences Inc | Terapeutisk behandling af androgenreceptor-betingede lidelser |
| EP3572417A3 (de) | 2011-10-14 | 2020-03-25 | Sage Therapeutics, Inc. | 3,3-disubstituierte 19-nor-pregnan verbindungen, zusammensetzungen damit und verwendungen davon |
| SG10201606063RA (en) | 2012-01-23 | 2016-09-29 | Sage Therapeutics Inc | Neuroactive steroid formulations and methods of treating cns disorders |
| IL304912A (en) | 2012-08-21 | 2023-10-01 | Sage Therapeutics Inc | Treatment methods for epilepsy and status epilepticus |
| KR102239541B1 (ko) | 2013-04-17 | 2021-04-14 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| RU2700264C2 (ru) | 2013-04-17 | 2019-09-16 | Сейдж Терапьютикс, Инк. | 19-нор нейроактивные стероиды и способы их применения |
| EP3868382A1 (de) | 2013-07-19 | 2021-08-25 | Sage Therapeutics, Inc. | Neuroaktive steroide, zusammensetzungen und verwendungen davon |
| LT3488852T (lt) | 2013-08-23 | 2021-02-25 | Sage Therapeutics, Inc. | Neuroaktyvūs steroidai, kompozicijos, ir jų naudojimas |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| BR112017007902B1 (pt) | 2014-10-16 | 2023-12-05 | Sage Therapeutics, Inc | Composto e seu sal, composição farmacêutica e uso do referido composto e seu sal na fabricação de um medicamento para o tratamento de distúrbios do sistema nervoso central |
| LT3206493T (lt) | 2014-10-16 | 2020-08-25 | Sage Therapeutics, Inc. | Kompozicijos ir būdai, skirti cns sutrikimams gydyti |
| SI3224269T1 (sl) | 2014-11-27 | 2020-10-30 | Sage Therapeutics, Inc. | Sestavki in metode za zdravljenje CNS motenj |
| ES2857082T3 (es) | 2015-01-26 | 2021-09-28 | Sage Therapeutics Inc | Composiciones y métodos para el tratamiento de trastornos del SNC |
| JP6875996B2 (ja) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| WO2017156103A1 (en) | 2016-03-08 | 2017-09-14 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| DK3481844T3 (da) | 2016-07-11 | 2024-07-22 | Sage Therapeutics Inc | C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse |
| MA45599A (fr) | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| WO2020243488A1 (en) | 2019-05-31 | 2020-12-03 | Sage Therapeutics, Inc. | Neuroactive steroids and compositions thereof |
-
0
- BE BE754111D patent/BE754111A/xx unknown
-
1969
- 1969-07-29 US US845877A patent/US3580937A/en not_active Expired - Lifetime
-
1970
- 1970-06-16 GB GB29169/70A patent/GB1279186A/en not_active Expired
- 1970-06-24 CH CH955170A patent/CH533095A/de not_active IP Right Cessation
- 1970-06-29 NL NL7009586A patent/NL7009586A/xx unknown
- 1970-07-18 DE DE19702035738 patent/DE2035738A1/de active Pending
- 1970-07-22 IL IL34974A patent/IL34974A/xx unknown
- 1970-07-28 FR FR7027781A patent/FR2059572B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE754111A (fr) | 1971-01-29 |
| US3580937A (en) | 1971-05-25 |
| NL7009586A (de) | 1971-02-02 |
| FR2059572B1 (de) | 1974-08-23 |
| FR2059572A1 (de) | 1971-06-04 |
| IL34974A0 (en) | 1970-09-17 |
| DE2035738A1 (de) | 1971-02-11 |
| GB1279186A (en) | 1972-06-28 |
| IL34974A (en) | 1974-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH533095A (de) | Verfahren zur Herstellung von Androstan-Verbindungen | |
| CH544093A (de) | Verfahren zur Herstellung von O-Acyl-lysergolen | |
| AT291933B (de) | Verfahren zur Herstellung von Magnesium-Alkohol-Verbindungen | |
| AT305417B (de) | Verfahren zur Herstellung von Schaltkreisen | |
| AT295743B (de) | Verfahren zur Herstellung von Bleomycinen | |
| CH543553A (de) | Verfahren zur Herstellung von Poly-amid-imid-estern | |
| AT299141B (de) | Verfahren zur Herstellung von 2-Äthylhexanol | |
| AT306715B (de) | Verfahren zur Herstellung von ω-Lactamen | |
| AT308075B (de) | Verfahren zur Herstellung von Monochlorbenzaldehyden | |
| AT313878B (de) | Verfahren zur Herstellung von Alkylophenolen | |
| AT300840B (de) | Verfahren zur Herstellung von Organo-H-silanen | |
| CH543487A (de) | Verfahren zur Herstellung von Adamantylharnstoffen | |
| CH544808A (de) | Verfahren zur Herstellung von Negamycin | |
| AT310769B (de) | Verfahren zur Herstellung von ɛ-Caprolacton | |
| AT324546B (de) | Verfahren zur herstellung von aminopenicillinen | |
| AT307418B (de) | Verfahren zur Herstellung von neuem 8-Cyano-5-octanolid | |
| CH504530A (de) | Verfahren zur Herstellung von Cytidin-diphosphat-cholin | |
| CH497425A (de) | Verfahren zur Herstellung von B-Picolin | |
| CH544758A (de) | Verfahren zur Herstellung von Lysergolen | |
| AT303377B (de) | Verfahren zur Herstellung von Polyolefinen | |
| AT301769B (de) | Verfahren zur Herstellung von neuen 21-Halogensteroiden | |
| AT314096B (de) | Verfahren zur Herstellung von substituierten Cobamiden | |
| CH523774A (de) | Verfahren zur Herstellung von Pressteilen | |
| AT303960B (de) | Verfahren zur herstellung von alpha-aminobenzylpenicillin | |
| CH539042A (de) | Verfahren zur Herstellung von Azamorphinanen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |